Showing 931-940 of 3738 results for "".
What ’s the Best Approach to AK Therapies? Ask an Expert
https://practicaldermatology.com/topics/skin-cancer-photoprotection/what-s-the-best-approach-to-ak-therapies-ask-an-expert/19622/Rather than consider AK a specific disease, Vishal A. Patel, MD, FAAD says it can be viewed as a marker of disease, which culminates in SCC. In this edition of Ask an Expert with Adam Friedman, MD, about his philosophy of treatment, including long-term maintenance.Seeing the Whole Picture, and When to Say "No"
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/seeing-the-whole-picture-and-when-to-say-no-/19084/You can turn patients down and still thrive. Heidi Waldorf, MD, FAAD and Steven Dayan, MD, FACS, Co-Chief Medical Editors of Modern Aesthetics®magazine, explain why and how you can tell patients "no," and offer tips for directing patients to a more appropriate intervention.Treatment Approaches for Psoriatic Arthritis
https://practicaldermatology.com/programs/practical-dermatology-il-17-journal-club/treatment-approaches-for-psoriatic-arthritis/48809/Naeim T. Issa, MD, PhD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the Mediterranean Journal of Rheumatology article “Emerging Targets in Psoriatic Arthritis: Dual IL-17A/F and Selective TYK2 Inhibition in a Clinical Perspective.”All Things Psoriasis With Dr. April Armstrong
https://practicaldermatology.com/podcasts/practical-dermatology-podcasts/all-things-psoriasis-with-dr-april-armstrong/36135/The latest news and updates, plus April W. Armstrong, MD, MPH, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the current state of psoriasis treatments, what's in the pipeline, her experience in leadership positions for multiple psoriasis organizations, and more.DermWire TV: Maui Derm Highlights, Plus New and Emerging Treatments for HS and Acne
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-maui-derm-highlights-plus-new-and-emerging-treatments-for-hs-and-acne/20258/In this episode of DermWire TV, we recap the biggest news from Maui Derm 2024, including safety and efficacy studies on bimekizumab, deucravacitinib, and upadacitinib. Also from Maui Derm, Raj Chovatiya, MD, PhD, highlights new therapies to treat hidradenitis suppurativa and Julie Harper, MD, highliGet the Gist
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/get-the-gist/19748/Practical Dermatology® magazine board member and co-host of "The Gist" on YouTube, Ava Shamban, MD speaks with Joel L. Cohen, MD about the program and its mission. Find out about upcoming episodes and watch Dr. Shamban address Dr. Cohen's request to visit the panel.Winning Combinations
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/winning-combinations/19740/When it comes to helping patients achieve a youthful look, it’s all about the journey, Suneel Chilukuri, MD tells host Joel L. Cohen, MD. You need to continuously update treatment recommendations as patients age and take advantage of combining neuromodulators, fillers, skincare, and energy-based devAK Treatment Pearls
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-treatment-pearls/19731/Joel Cohen, MD and George Martin, MD go in depth to discuss nuances of treating actinic keratosis in a wide ranging conversation covering the concept of painless PDT and how pretreatment may enhance penetration, an update on ingenol mebutate, and a potential role for combination calcipotriene and 5-Neuromodulators in Medical Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neuromodulators-in-medical-dermatology/18520/Physicians are exploring the effects of botulinum toxins on several medical dermatology conditions. Erin Gilbert, MD talks to Joel Cohen, MD about her experience treating rosacea, and discusses the need for better randomized trials to explore treatment options.To Sell or Not to Sell to Private Equity?
https://practicaldermatology.com/conferences/scale-2023/to-sell-or-not-to-sell-to-private-equity/20195/Joel L. Cohen, MD, and George Hruza MD, discuss the pros and cons of selling to private equity. Pros include back-office support and better pricing on technology and supplies, while cons can include giving up autonomy.